This Viewpoint discusses the strategy of “rational dispersion” for new technology into clinical practice, and proposes patient and clinical selection criteria, follow-up and registry surveillance, and regionalization strategies that would guide rational staged rollout of transcatheter technology for mitral valve repair (TMVR).
This Viewpoint discusses integration of sensors to metered dose inhalers (MDIs) that provide measures of actuation and adherence and calls on physicians and manufacturers to make monitor-derived adherence measures a standard component of management of asthma, chronic obstructive pulmonary disease (COPD), and other MDI-treated lung disease.
This Viewpoint describes trends favoring private equity acquisition of health care practices and companies, and calls for research to better characterize potential risks and benefits relative to health care quality, outcomes, and costs.
This Viewpoint characterizes the evidence base underlying existing interventions to reduce complications and improve patient outcomes after surgery, and emphasizes the need for science to guide extension and development of new interventions in the face of pressures to use length-of-stay (LOS) as the primary measure of enhanced recovery and to use interventions shown effective for one population and setting to others.
In this narrative medicine essay, a palliative care physician’s experience—holding the hand of a man who was flung to a curb after miscalculating a light change as he dashed across the street causing him to be struck by truck—cured her of fainting at the sight of pain, which enabled her to choose a career in palliative care.
This randomized trial compares the effects of pulmonary vein isolation using radiofrequency ablation vs antiarrhythmic medication on self-reported quality of life at 1 year in patients with atrial fibrillation and previous medication failure.
This systematic review of current and prior American College of Cardiology/American Heart Association and European Society of Cardiology guidelines summarizes the class and level of evidence (LOE) supporting guideline recommendations and changes in LOEs over time.
This pooled cohort study reports that consumption of an additional 300 mg of dietary cholesterol per day or an additional half egg per day is significantly associated with higher risk of incident cardiovascular disease (CVD) events and all-cause mortality.
This JAMA Guide to Statistics and Methods reviews considerations that go into investigators’ choice of time over which to define and measure the benefits and costs of interventions in risk-benefit and cost-effectiveness analyses.
This Clinical Update reviews the technologies underlying dysrhythmia detection by Apple's smartwatch and other personal mobile devices, accuracy of the devices for detecting atrial fibrillation and clinically significant tachycardias and bradycardia, and it proposes an algorithm for how clinicians should respond to each.
This JAMA Clinical Guidelines Synopsis summarizes the AHA/ACC/HRS 2019 update of the societies’ guideline for managing patients with atrial fibrillation, focusing on use of novel oral anticoagulants (NOACs) and procedural interventions such as left atrial appendage closure (LAAC) and catheter ablation.
This study examines whether Catholic hospitals disclose their religious identity and health care practices based on the church’s teachings on their websites.
This Medical News story discusses initiatives aimed at improving recovery from life-threatening illnesses after release from the intensive care unit.
This Medical News & Perspectives article describes a report showing that the prevalence of atopic eczema rebounds in older adults.
This JAMA Patient Page describes why and how cardiac catheter ablation is used to correct atrial fibrillation and other heart rhythm abnormalities.
Create a personal account or sign in to: